Arnoldi A, Bonsignori A, Melloni P, Merlini L, Quadri M L, Rossi A C, Valsecchi M
Dipartimento di Scienze Molecolari Agroalimentari, Università di Milano, Italy.
J Med Chem. 1990 Oct;33(10):2865-9. doi: 10.1021/jm00172a030.
A series of 4-(alkylimino)-5-hydroxy-7-alkyl-2,3-dihydro-4H-1-benzopyrans and -thiopyrans were synthesized and evaluated for anticonvulsant activity. Preliminary screening of these compounds revealed that 2,2-dimethyl-4-[(2-hydroxyalkyl)imino]-5-hydroxy-7-pentyl-2,3- dihydro-4H-1-benzopyrans 19 and 29, the 7-butyl analogue 34, and the corresponding 7-pentyl-4H-1-benzothiopyrans 38 and 39 had the most promising anticonvulsant activity. Synthesis of both enantiomers of 29 and 39 indicated that the R isomers 30 and 40 were the most active and showed very good protection against MES, pentylenetetrazole, and mercaptopropionic acid induced seizures after oral administration in mice. In the Irwin test these compounds showed a generalized depressant activity but at dosages higher than those showing anticonvulsant activity, whereas acute toxicity after oral administration was low (LD50 higher than 400 mg/kg).
合成了一系列4-(烷基亚氨基)-5-羟基-7-烷基-2,3-二氢-4H-1-苯并吡喃和-硫代苯并吡喃,并对其抗惊厥活性进行了评估。对这些化合物的初步筛选表明,2,2-二甲基-4-[(2-羟烷基)亚氨基]-5-羟基-7-戊基-2,3-二氢-4H-1-苯并吡喃19和29、7-丁基类似物34以及相应的7-戊基-4H-1-苯并硫代吡喃38和39具有最有前景的抗惊厥活性。29和39的两种对映体的合成表明,R-异构体30和40活性最高,在小鼠口服给药后对最大电休克(MES)、戊四氮和巯基丙酸诱导的惊厥表现出很好的保护作用。在欧文试验中,这些化合物表现出全身抑制活性,但剂量高于显示抗惊厥活性的剂量,而口服给药后的急性毒性较低(半数致死量高于400 mg/kg)。